Brief: Targovax Q2 Operating Loss Narrows To NOK 29.7 Mln
Aug 20 (Reuters) - Targovax ASA TRVX.OL :
* Q2 TOTAL OPERATING REVENUE NOK 272,000 VERSUS NOK 6,000
YEAR AGO
* Q2 OPERATING LOSS NOK 29.7 MILLION VERSUS LOSS NOK 44.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr5ZG588
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration